Skip to main content

Table 4 CESM in predicting pCR

From: Predicting response to neo-adjuvant chemotherapy and assessment of residual disease in breast cancer using contrast-enhanced spectral mammography: a combined qualitative and quantitative approach

 

Pathologic response

Complete responder

Incomplete responder

Count

%

Count

%

RECIST 1.1 evaluation

CR

20/21

95.23%

1/60

1.7%

ICR

1/21

4.76%

59/60

98.3%

Combined response evaluation

CR

20/21

95.23

1/60

1.7%

ICR

1/21

4.76%

59/60

98.3%